Telix Pharmaceuticals Statistics
Total Valuation
TLX has a market cap or net worth of $3.82 billion. The enterprise value is $4.16 billion.
| Market Cap | 3.82B |
| Enterprise Value | 4.16B |
Important Dates
The last earnings date was Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TLX has 339.78 million shares outstanding. The number of shares has increased by 2.75% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 339.78M |
| Shares Change (YoY) | +2.75% |
| Shares Change (QoQ) | +5.42% |
| Owned by Insiders (%) | 14.83% |
| Owned by Institutions (%) | 44.71% |
| Float | 273.62M |
Valuation Ratios
The trailing PE ratio is 114.14 and the forward PE ratio is 496.93.
| PE Ratio | 114.14 |
| Forward PE | 496.93 |
| PS Ratio | 4.29 |
| Forward PS | 3.98 |
| PB Ratio | 7.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 124.29 |
| EV / Sales | 4.67 |
| EV / EBITDA | 59.64 |
| EV / EBIT | 75.34 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 1.19.
| Current Ratio | 2.01 |
| Quick Ratio | 1.74 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 7.47 |
| Debt / FCF | n/a |
| Interest Coverage | 3.69 |
Financial Efficiency
Return on equity (ROE) is 7.37% and return on invested capital (ROIC) is 6.78%.
| Return on Equity (ROE) | 7.37% |
| Return on Assets (ROA) | 2.71% |
| Return on Invested Capital (ROIC) | 6.78% |
| Return on Capital Employed (ROCE) | 4.94% |
| Weighted Average Cost of Capital (WACC) | 6.82% |
| Revenue Per Employee | $752,352 |
| Profits Per Employee | $28,291 |
| Employee Count | 1,184 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 12.58 |
Taxes
| Income Tax | -4.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.90% in the last 52 weeks. The beta is 0.60, so TLX's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +19.90% |
| 50-Day Moving Average | 11.15 |
| 200-Day Moving Average | 9.42 |
| Relative Strength Index (RSI) | 52.12 |
| Average Volume (20 Days) | 138,894 |
Short Selling Information
The latest short interest is 244,900, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 244,900 |
| Short Previous Month | 277,664 |
| Short % of Shares Out | 0.08% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.32 |
Income Statement
In the last 12 months, TLX had revenue of $890.79 million and earned $33.50 million in profits. Earnings per share was $0.10.
| Revenue | 890.79M |
| Gross Profit | 423.71M |
| Operating Income | 55.26M |
| Pretax Income | 28.82M |
| Net Income | 33.50M |
| EBITDA | 69.81M |
| EBIT | 55.26M |
| Earnings Per Share (EPS) | $0.10 |
Balance Sheet
The company has $251.91 million in cash and $579.86 million in debt, with a net cash position of -$327.95 million or -$0.97 per share.
| Cash & Cash Equivalents | 251.91M |
| Total Debt | 579.86M |
| Net Cash | -327.95M |
| Net Cash Per Share | -$0.97 |
| Equity (Book Value) | 487.68M |
| Book Value Per Share | 1.44 |
| Working Capital | 245.68M |
Cash Flow
In the last 12 months, operating cash flow was -$12.01 million and capital expenditures -$33.48 million, giving a free cash flow of -$45.49 million.
| Operating Cash Flow | -12.01M |
| Capital Expenditures | -33.48M |
| Depreciation & Amortization | 14.55M |
| Net Borrowing | 115.13M |
| Free Cash Flow | -45.49M |
| FCF Per Share | -$0.13 |
Margins
Gross margin is 47.57%, with operating and profit margins of 6.20% and 3.76%.
| Gross Margin | 47.57% |
| Operating Margin | 6.20% |
| Pretax Margin | 3.24% |
| Profit Margin | 3.76% |
| EBITDA Margin | 7.84% |
| EBIT Margin | 6.20% |
| FCF Margin | n/a |
Dividends & Yields
TLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.75% |
| Shareholder Yield | -2.75% |
| Earnings Yield | 0.88% |
| FCF Yield | -1.19% |
Analyst Forecast
The average price target for TLX is $21.49, which is 87.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.49 |
| Price Target Difference | 87.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 15.31% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TLX has an Altman Z-Score of 3.19 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.19 |
| Piotroski F-Score | 3 |